IBRUTINIB (ibrutinib) by Teva is protein kinase inhibitors [moa].
Drug data last refreshed 1mo ago
Protein Kinase Inhibitors
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Remibrutinib Open Label Roll-over Post-trial Access Protocol
A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS
Remibrutinib in Real-world Clinical Practice - a US Sub-study
Remibrutinib in Real-world Clinical Practice
A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
Worked on IBRUTINIB at Teva? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.